iSpecimen Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-11.1	-10.25	-8.96	-4.65	-4.73
Depreciation & Amortization	2.07	1.21	1	0.82	0.63
Share-Based Compensation	0.46	0.68	0.62	0.09	0.36
Other Operating Activities	2.77	2.54	-3.33	3.45	1.05
Operating Cash Flow	-5.81	-5.82	-10.67	-0.29	-2.68
Capital Expenditures	-4.74	-3.19	-1.04	-1.1	-1.48
Change in Investments	-2.48	0	0	0	0
Investing Cash Flow	-7.23	-3.19	-1.04	-1.1	-1.48
Share Issuance / Repurchase	0.07	0.08	37.78	0	0
Debt Issued / Paid	0	-3.5	0.97	2.03	3.08
Financing Cash Flow	0.07	-3.42	38.75	2.03	3.08
Net Cash Flow	-12.97	-12.43	27.04	0.64	-1.08
Free Cash Flow	-10.55	-9.01	-11.71	-1.39	-4.16
Free Cash Flow Margin	-106.28%	-86.60%	-105.13%	-17.00%	-96.67%
Free Cash Flow Per Share	-1.17	-1.02	-2.73	-1.49	-4.44

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).